Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 26 | 59 | 5 | 2 | 6 | 85 |
Multiple myeloma | D009101 | — | C90.0 | 8 | 12 | 2 | 1 | — | 19 |
Germ cell and embryonal neoplasms | D009373 | — | — | 3 | 6 | 1 | 1 | 3 | 12 |
Plasma cell neoplasms | D054219 | — | — | 3 | 7 | 2 | 1 | — | 11 |
Sclerosis | D012598 | — | — | 4 | 4 | 4 | 1 | — | 11 |
T-cell lymphoma | D016399 | — | — | 1 | 7 | — | 2 | — | 9 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | 3 | 3 | 3 | 1 | — | 8 |
Diffuse scleroderma | D045743 | EFO_0000404 | — | 3 | 3 | 3 | 1 | — | 8 |
T-cell lymphoma peripheral | D016411 | — | — | 1 | 5 | — | 2 | — | 7 |
Medulloblastoma | D008527 | — | — | 1 | 2 | 2 | 1 | 1 | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 29 | 48 | 6 | — | 4 | 75 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 15 | 32 | 4 | — | 1 | 45 |
Sarcoma | D012509 | — | — | 12 | 19 | 7 | — | 4 | 37 |
Neoplasms | D009369 | — | C80 | 19 | 20 | 1 | — | 3 | 35 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 13 | 26 | 1 | — | 3 | 34 |
Lymphoid leukemia | D007945 | — | C91 | 12 | 24 | 4 | — | — | 34 |
Myelodysplastic syndromes | D009190 | — | D46 | 10 | 17 | 1 | — | 2 | 25 |
Myeloid leukemia acute | D015470 | — | C92.0 | 10 | 15 | 1 | — | 1 | 24 |
Myeloid leukemia | D007951 | — | C92 | 8 | 18 | 1 | — | — | 24 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 7 | 15 | 2 | — | — | 18 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hematologic neoplasms | D019337 | — | — | 12 | 19 | — | — | 1 | 24 |
Melanoma | D008545 | — | — | 9 | 15 | — | — | 1 | 22 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 11 | 12 | — | — | 1 | 18 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 2 | 12 | — | — | — | 12 |
Syndrome | D013577 | — | — | 2 | 8 | — | — | 1 | 9 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 2 | 9 | — | — | — | 9 |
Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 3 | 7 | — | — | — | 8 |
Primary myelofibrosis | D055728 | — | D47.4 | 3 | 5 | — | — | — | 8 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 3 | 6 | — | — | — | 7 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 5 | 6 | — | — | — | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Wilms tumor | D009396 | EFO_0000212 | — | 2 | — | — | — | — | 2 |
Rhabdoid tumor | D018335 | — | — | 1 | — | — | — | 1 | 2 |
Ganglioneuroblastoma | D018305 | — | — | 1 | — | — | — | — | 1 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | — | — | — | — | 1 |
Vasculitis | D014657 | EFO_0006803 | M31 | 1 | — | — | — | — | 1 |
Myositis | D009220 | EFO_0000783 | G72.49 | 1 | — | — | — | — | 1 |
Muscular diseases | D009135 | EFO_0002970 | G72.9 | 1 | — | — | — | — | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | — | 1 |
Myasthenia gravis | D009157 | EFO_0004991 | G70.0 | 1 | — | — | — | — | 1 |
Muscle weakness | D018908 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Nausea | D009325 | — | R11.0 | — | — | — | — | 2 | 2 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
Aggression | D000374 | EFO_0003015 | — | — | — | — | — | 1 | 1 |
Histiocytosis | D015614 | HP_0100727 | — | — | — | — | — | 1 | 1 |
Langerhans-cell histiocytosis | D006646 | — | C96.6 | — | — | — | — | 1 | 1 |
Wiskott-aldrich syndrome | D014923 | EFO_0003903 | D82.0 | — | — | — | — | 1 | 1 |
Severe combined immunodeficiency | D016511 | — | D81.0 | — | — | — | — | 1 | 1 |
Hemophagocytic lymphohistiocytosis | D051359 | — | D76.1 | — | — | — | — | 1 | 1 |
Chronic granulomatous disease | D006105 | EFO_0000338 | D71 | — | — | — | — | 1 | 1 |
Type 1 hyper-igm immunodeficiency syndrome | D053307 | — | — | — | — | — | — | 1 | 1 |